Implications of the revised surveillance definition: AIDS among New York City drug users.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1359800.
- Also identified by PMC identifier 1694601.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Centers for Disease Control (CDC) has proposed revising the AIDS surveillance definition to include any HIV-seropositive person with a CD4 cell count of less than 200 cells per microliter. Based on a study of persons receiving treatment for HIV infection, this new definition would lead to an estimated 50% increase in the number of persons recognized as living with AIDS. Among 440 HIV-seropositive research subjects recruited from drug treatment programs and through street outreach in New York City, 59 met this definition, yet only 25% of those had been reported to the New York City AIDS registry. The new definition, if combined with HIV and T-cell testing at drug treatment and street outreach programs, could thus yield very large increases in the number of injecting drug users meeting the new surveillance definition of AIDS.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- CD4-Positive T-Lymphocytes
- HIV Seropositivity
- HIV Seroprevalence
- Population Surveillance
- Substance Abuse, Intravenous